SB5 (BIIB606)- adalimumab-bwwd injection, solution
Catalent Indiana, LLC
----------
SB5 (BIIB606)
adalimumab-bwwd injection, solution
Product Information
Product Type
HUMAN PRESCRIPTION DRUG
Item Code (Source)
NDC:61434-005
Route of Administration
INTRAVENOUS
Active Ingredient/Active Moiety
Ingredient Name
Basis of Strength
Strength
ADALIMUMAB-BWWD
(UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842)
ADALIMUMAB-BWWD
40 mg in 0.8 mL
Packaging
#
Item Code
Package Description
Marketing Start Date
Marketing End Date
1
NDC:61434-005-00
1280 in 1 CASE
08/27/2017
1
0.8 mL in 1 SYRINGE, GLASS; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing Category
Application Number or Monograph Citation
Marketing Start Date
Marketing End Date
export only
08/27/2017
Labeler -
Catalent Indiana, LLC (172209277)
Revised: 10/2023
Document Id:
caaddefa-e807-4d47-8ac5-e6b87bd02055
34391-3
Set id: 002d3e04-7558-4e22-85bb-09e30566bd0b
Version: 10
Effective Time: 20231006
Catalent Indiana, LLC